Windlas Biotech Limited (NSE:WINDLAS)
India
· Delayed Price · Currency is INR 743.35
-11.70 (-1.55%)
At close: Mar 6, 2026
Windlas Biotech Revenue
Windlas Biotech had revenue of 2.33B INR in the quarter ending December 31, 2025, with 19.53% growth. This brings the company's revenue in the last twelve months to 8.68B, up 19.20% year-over-year. In the fiscal year ending March 31, 2025, Windlas Biotech had annual revenue of 7.60B with 20.43% growth.
Revenue (ttm)
8.68B
Revenue Growth
+19.20%
P/S Ratio
1.79
Revenue / Employee
6.45M
Employees
1,346
Market Cap
15.58B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 17.60B |
| Ind-Swift Laboratories | 5.94B |
| Sakar Healthcare | 2.31B |
| Jagsonpal Pharmaceuticals | 2.82B |
| Beta Drugs | 3.85B |
| Solara Active Pharma Sciences | 12.55B |
| Orchid Pharma | 8.11B |
| RPG Life Sciences | 6.74B |